Johnson, M., Morrison, F. J., McMahon, G., Su, M., & Turchin, A. (2023). Outcomes in patients with cardiometabolic disease who develop hyperkalemia while treated with a renin-angiotensin-aldosterone system inhibitor. American Heart Journal, 258, 49–59. https://doi.org/10.1016/j.ahj.2023.01.002

Qin, L., Zhang, N., Ishigami, J., Miller, E. R., Pfister, M., Moran, A. E., & Cox, E. (2021). Dyskalemia risk associated with fixed-dose anti-hypertensive medication combinations. Journal of Human Hypertension, 36(11), 989–995. https://doi.org/10.1038/s41371-021-00600-w